CTIS.eu › Cities › Italy › Rome
Rome
Italy
2,096 total trials
907 recruiting
Filter these 2,096 trials by phase, condition, sponsor and more.
Open in Search →
2023-504885-50-00
5
2022-11-07
Treatment of children with chronic kidney disease and proteinuria
2023-504264-41-00
9
2022-11-04
CD20 positive B-Cell Non-Hodgkin Lymphoma (NHL)
2024-514266-39-00
7
2022-11-03
Advanced Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors wit
2024-514641-12-00
5
2022-10-26
Transfusion-dependent β-thalassemia (TDT)
2023-508425-28-00
4
2022-10-24
Chronic Inflammatory Demyelinating Polyneuropathy
2023-503442-30-00
5
2022-10-14
Multiple Myeloma
2023-510240-20-00
4
2022-10-05
Adult Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.
2024-512382-13-00
5
2022-10-04
Migraine (with or without aura)
2023-508129-28-00
9
2022-09-28
Pediatric patients with Philadelphia chromosome positive chronic myelo
2023-508868-30-00
5
2022-09-26
Treatment of stereotypical prolonged seizure
2023-510384-36-00
5
2022-09-13
Newly Diagnosed Multiple Myeloma
2023-510346-25-00
5
2022-09-01
Hypereosinophilic Syndrome (HES)
2023-507557-16-00
5
2022-08-31
chronic myelogenous leukemia (CML) or Philadelphia Chromosome positive
2024-512822-28-00
1
2022-08-08
Advanced or metastatic solid tumors
2024-510950-29-00
5
2022-07-21
Stereotypical prolonged seizure
2024-513978-22-00
5
2022-07-20
Severe sickle cell disease (SCD)
2024-511635-94-00
4
2022-07-11
Relapsed or Refractory Plasmablastic lymphoma
2023-508534-33-00
10
2022-06-16
Neuromyelitis Optica Spectrum Disorder (NMOSD)
2023-503267-42-00
5
2022-06-10
Patients with a histological diagnosis of mismatch- repair deficient h
2023-508852-21-00
4
2022-06-10
Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer
2023-503651-10-00
7
2022-05-17
Male and female participants ≥ 18 years of age with advanced or
metast
2024-513349-35-00
5
2022-05-16
Transfusion-Dependent-Thalassemia
2024-513412-10-00
9
2022-05-11
Anaplastic Large Cell Lymphoma (ALCL)
2023-506891-28-00
5
2022-05-02
The target population of interest in this study is participants with l
Showing 985–1,008 of 2,096 trials